How has Geisinger reduced device costs in clinically sensitive areas? Attend a webinar, March 7
Skip to Content
Research & Insights Whitepapers

Evidence Insight Spotlight: MAKO from Stryker

Is MAKO’s cost justified by the clinical outcomes?

MAKO from Stryker is a robotic orthopedic surgical system used in joint replacement surgeries to achieve highly accurate implant placement. Due to high acquisition and operating costs, health systems must weigh the clinical evidence before adopting this technology.

Download this article to:

  • View MAKO’s operational and clinical outcomes compared to manual surgery across three procedure types
  • Read our evidence-based adoption recommendations for this technology
  • Inform purchasing decisions on a $1M+ outlay